SUBSCRIBE
SUBSCRIBE

Roche

NEWS
Novartis to Hold On to Its 33% Stake in Roche—For Now
Deals
Novartis AG Mulls Over Selling $14 Billion Roche Stake to Potentially Free Up Cash for New Deals
April 25, 2016
 · 
3 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Biotech Bay
Backed by Pfizer and Roche, Bay Area’s Second Genome Nabs $42.6 Million
April 20, 2016
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Pharm Country
Johnson & Johnson and Roche Could Be the Storm Off Celgene’s Horizon
March 24, 2016
 · 
3 min read
Biotech Bay
The 8 Best Pharmaceutical Companies to Work for
Looking for the best pharmaceutical companies to work for? Here’s the list of the top 8 pharma companies that are hiring right now. So, let’s check the list.
March 16, 2016
 · 
8 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Novartis AG’s Leukemia Drug Gets Breakthrough Designation, Same Week as AstraZeneca PLC and Roche Drugs
February 19, 2016
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Roche’s Multiple Sclerosis Drug Gets Breakthrough Status, Likely to Haunt Biogen
February 17, 2016
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Bay Area’s Pacific Biosciences Stock Pops on Roche Acquisition Bid Rumors
February 3, 2016
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Off Label Use of Roche’s Avastin in India Puts 15 in the Hospital, Prompts Officials to Halt Using the Drug
January 20, 2016
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
C4 Therapeutics Launches With $73 Million Series A and a Roche Deal Potentially Worth $750 Million
January 7, 2016
 · 
3 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
JOBS
IN THE PRESS
Press Releases
FDA Grants Priority Review To Genentech’s Application for Enspryng, the First and Only At-Home Subcutaneous Treatment Option for Thyroid Eye Disease (TED)
June 30, 2026
 · 
10 min read
Press Releases
FDA grants Priority Review to Roche’s Enspryng, the first and only at-home subcutaneous treatment option for thyroid eye disease (TED)
June 30, 2026
 · 
8 min read
Press Releases
Excalipoint Therapeutics Announces Clinical Trial Collaboration with Roche to Evaluate EXP011 in DLL3‑Expressing Solid Tumors
June 29, 2026
 · 
2 min read
Press Releases
Roche announces the launch of AXELIOS 1, a transformative next-generation sequencing platform
June 29, 2026
 · 
7 min read
Press Releases
Gazyva® (obinutuzumab) receives positive reimbursement recommendation from the Institut national d’excellence en santé et en services sociaux (INESSS) for persons with active lupus nephritis
June 25, 2026
 · 
6 min read
Press Releases
Roche Canada and the pan-Canadian Pharmaceutical Alliance (pCPA) have successfully completed negotiations for Itovebi® (inavolisib), a targeted treatment for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
June 23, 2026
 · 
5 min read
Press Releases
FDA accepts supplemental Biologics License Application for Roche’s Lunsumio and Polivy combination for people with relapsed or refractory large B-cell lymphoma
June 18, 2026
 · 
11 min read
Press Releases
Gero Reaches $34M in Equity Funding to Turn the Physics of Aging Into Medicines
June 17, 2026
 · 
5 min read
Press Releases
IDEAYA Biosciences Announces IDE892, a Potential Best-in-Class MTA-Cooperative PRMT5 Inhibitor, Initiates a Phase 1/2 Clinical Combination Study in MTAP-Deleted Pancreatic and Lung Cancers
June 15, 2026
 · 
6 min read
Press Releases
Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer
June 14, 2026
 · 
5 min read
Load More